DK1066287T3 - Azatricykliske forbindelser - Google Patents

Azatricykliske forbindelser

Info

Publication number
DK1066287T3
DK1066287T3 DK99908541T DK99908541T DK1066287T3 DK 1066287 T3 DK1066287 T3 DK 1066287T3 DK 99908541 T DK99908541 T DK 99908541T DK 99908541 T DK99908541 T DK 99908541T DK 1066287 T3 DK1066287 T3 DK 1066287T3
Authority
DK
Denmark
Prior art keywords
hydrogen
substituent
sigma
species characterized
nitrogen
Prior art date
Application number
DK99908541T
Other languages
Danish (da)
English (en)
Inventor
Peter Anthony Crooks
Niranjan Madhukar Deo
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Application granted granted Critical
Publication of DK1066287T3 publication Critical patent/DK1066287T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Luminescent Compositions (AREA)
DK99908541T 1998-04-02 1999-02-26 Azatricykliske forbindelser DK1066287T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/054,179 US5986100A (en) 1998-04-02 1998-04-02 Pharmaceutical compositions and methods for use
PCT/US1999/004324 WO1999051601A1 (en) 1998-04-02 1999-02-26 Azatricyclic compounds

Publications (1)

Publication Number Publication Date
DK1066287T3 true DK1066287T3 (da) 2004-01-19

Family

ID=21989278

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99908541T DK1066287T3 (da) 1998-04-02 1999-02-26 Azatricykliske forbindelser

Country Status (14)

Country Link
US (2) US5986100A (de)
EP (1) EP1066287B1 (de)
JP (1) JP2002510689A (de)
KR (1) KR100613050B1 (de)
AT (1) ATE248839T1 (de)
AU (1) AU2794899A (de)
BR (1) BR9907191A (de)
CA (1) CA2317570A1 (de)
DE (1) DE69910993T2 (de)
DK (1) DK1066287T3 (de)
ES (1) ES2205778T3 (de)
MX (1) MXPA00009624A (de)
PT (1) PT1066287E (de)
WO (1) WO1999051601A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID27544A (id) * 1998-08-18 2001-04-12 Ucb Sa Agonis dan antagonis muskarinat
AU2002360598B2 (en) * 2001-12-14 2008-02-14 Medical College Of Georgia Research Institute, Inc. Methods and compositions for treatment of central nervous system disorders
US20030162770A1 (en) 2002-02-22 2003-08-28 Davis Bonnie M. Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
US7897766B2 (en) * 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
AU2012203831B2 (en) * 2006-11-06 2013-12-19 Abbvie Bahamas Ltd Azaadamantane derivatives and their uses as nicotinic acetylcholine receptors ligands
MX2009010175A (es) 2007-03-23 2009-10-12 Abbott Lab Derivados de acetamida y carboxamida de aza-adamantano y metodos de uso de los mismos.
MX2009010176A (es) * 2007-03-23 2009-10-12 Abbott Lab Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos.
US9464078B2 (en) 2010-09-23 2016-10-11 Abbvie Inc. Monohydrate of azaadamantane derivatives
US12084472B2 (en) 2015-12-18 2024-09-10 Ardelyx, Inc. Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身ｔｇｒ５促效劑之經取代之4-苯基吡啶化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03135978A (ja) * 1989-08-08 1991-06-10 Merck Sharp & Dohme Ltd 置換ピリジン、その製法、処方並びに痴呆症における使用法
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
EP0492903A1 (de) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituierte Pyrazine, Pyrimidine und Pyridazine zur Anwendung in der Behandlung von Glaukoma
AU7474794A (en) * 1993-07-22 1995-02-20 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
AU5383196A (en) * 1995-05-17 1996-11-29 R.J. Reynolds Tobacco Company Pharmaceutical compositions for prevention and treatment of central nervous system disorders
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
US5684159A (en) * 1995-05-30 1997-11-04 Rhone-Poulenc Rorer S.A. L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1!heptane compounds

Also Published As

Publication number Publication date
DE69910993D1 (de) 2003-10-09
WO1999051601A1 (en) 1999-10-14
ATE248839T1 (de) 2003-09-15
US5986100A (en) 1999-11-16
BR9907191A (pt) 2000-12-26
DE69910993T2 (de) 2004-07-22
PT1066287E (pt) 2004-01-30
EP1066287A1 (de) 2001-01-10
EP1066287B1 (de) 2003-09-03
ES2205778T3 (es) 2004-05-01
AU2794899A (en) 1999-10-25
CA2317570A1 (en) 1999-10-14
MXPA00009624A (es) 2005-06-20
US6211372B1 (en) 2001-04-03
KR20010052172A (ko) 2001-06-25
KR100613050B1 (ko) 2006-08-25
JP2002510689A (ja) 2002-04-09

Similar Documents

Publication Publication Date Title
TW328535B (en) Functional photoinitiators and their manufacture
ZA983055B (en) Fungicidal trifluorophenyl-triazolopyrimidines.
AU2003222450A1 (en) Stabilized ascorbic acid derivatives
PT1066287E (pt) Compostos azatriciclicos
PT1447400E (pt) Composto bicíclico
GEP20043172B (en) Combination Chemotherapy
TWI265969B (en) Liquid-crystalline medium having a high birefringence and improved UV stability
ATE240331T1 (de) Azatricyclo(3.3.1.1)decanderivate und diese enthaltende phrmazeutische zubereitungen
EP0945764A3 (de) Fotoresistzusammensetzung
MY114174A (en) Insecticidal tetrahydrofuran-compound
HK1042920A1 (zh) 抗氧化劑
MY133299A (en) Skin moisturizing composition comprising a choline salt
WO1999009965A3 (en) Anti-inflammatory agent
EP1398306A3 (de) Ein (1'R,2'S,5'R)-3-l-Menthoxypropan-1-ol, das eine kühlende Empfindung erzeugt
BR0012830A (pt) Silanos fenólicos bloqueados
EP0953605A3 (de) Polycarbonatabmischung mit verbessertem Fliessverhalten
CA2191947A1 (en) Pirydyl Imidazole Derivatives and Processes for the Preparation Thereof
EP1378502A4 (de) Kettenförmiger oligomilchsäureester
BG107048A (en) Method for the preparation of citalopram
IL152632A0 (en) Trimethyldecenyl compounds
WO2002072062A3 (en) Skin moisturizing composition
GB9920959D0 (en) Novel process
DK1317461T3 (da) 4-Cyclohexyl-1,3,2-oxazaborolidiner som chirale hjælpestoffer
DK0963998T3 (da) Azasteroidforbindelse til behandling eller prævention af prostatacancer
EP1826214B8 (de) Zusammensetzung enthaltend Ferrocen-Derivate und Treibstoff diese enthaltend